[go: up one dir, main page]

WO2021173865A3 - Compounds for detection of viral pathogens - Google Patents

Compounds for detection of viral pathogens Download PDF

Info

Publication number
WO2021173865A3
WO2021173865A3 PCT/US2021/019720 US2021019720W WO2021173865A3 WO 2021173865 A3 WO2021173865 A3 WO 2021173865A3 US 2021019720 W US2021019720 W US 2021019720W WO 2021173865 A3 WO2021173865 A3 WO 2021173865A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
detection
viral pathogens
pathogens
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2021/019720
Other languages
French (fr)
Other versions
WO2021173865A2 (en
Inventor
Satish C. AGRAWAL
Prakash Rai
Michael P. Filosa
Peter Tzuyu WEN
Robb J. Osinski
Michael G. Horner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bambu Vault LLC
Original Assignee
Bambu Vault LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bambu Vault LLC filed Critical Bambu Vault LLC
Publication of WO2021173865A2 publication Critical patent/WO2021173865A2/en
Publication of WO2021173865A3 publication Critical patent/WO2021173865A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The disclosure provides compositions and methods of use thereof to detect pathogenic viruses like coronavirus.
PCT/US2021/019720 2020-02-25 2021-02-25 Compounds for detection of viral pathogens Ceased WO2021173865A2 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US202062981408P 2020-02-25 2020-02-25
US62/981,408 2020-02-25
US202063012779P 2020-04-20 2020-04-20
US63/012,779 2020-04-20
US202063014476P 2020-04-23 2020-04-23
US63/014,476 2020-04-23
US202063035438P 2020-06-05 2020-06-05
US63/035,438 2020-06-05
US202063037239P 2020-06-10 2020-06-10
US63/037,239 2020-06-10

Publications (2)

Publication Number Publication Date
WO2021173865A2 WO2021173865A2 (en) 2021-09-02
WO2021173865A3 true WO2021173865A3 (en) 2021-10-21

Family

ID=77490213

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2021/019720 Ceased WO2021173865A2 (en) 2020-02-25 2021-02-25 Compounds for detection of viral pathogens

Country Status (1)

Country Link
WO (1) WO2021173865A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023219136A1 (en) * 2022-05-12 2023-11-16 国立大学法人 東京大学 Fluorescent probe for detecting peptide-linked hydrolase
CN117604067A (en) * 2022-05-20 2024-02-27 张玥 Novel coronavirus detection method, detection card, detection kit and protective mask
CN116621939B (en) * 2023-05-17 2024-01-19 吉林农业大学 Application of antibacterial peptide LRGG in preparation of fluoroquinolone antibacterial synergist
WO2025022395A1 (en) * 2023-07-24 2025-01-30 Ramot At Tel-Aviv University Ltd. Colorimetric detection of a viral infection
CN118222733B (en) * 2024-04-07 2025-06-27 杭州迪安医学检验中心有限公司 PCR detection composition for Mycobacterium tuberculosis and tongue swab detection kit thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110065091A1 (en) * 2003-08-18 2011-03-17 Van Der Hoek Cornelia Maria Coronavirus, Nucleic Acid, Protein, and Methods for the Generation of Vaccine, Medicaments and Diagnostics
US20130296186A1 (en) * 1997-10-06 2013-11-07 Trustees Of Tufts College, Tufts University Self-encoding sensor with microspheres
US20160231324A1 (en) * 2013-09-24 2016-08-11 The Regents Of The University Of California Encapsulated sensors and sensing systems for bioassays and diagnostics and methods for making and using them
US20180059117A1 (en) * 2006-10-06 2018-03-01 Sirigen Inc. Fluorescent methods and materials for directed biomarker signal amplification

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130296186A1 (en) * 1997-10-06 2013-11-07 Trustees Of Tufts College, Tufts University Self-encoding sensor with microspheres
US20110065091A1 (en) * 2003-08-18 2011-03-17 Van Der Hoek Cornelia Maria Coronavirus, Nucleic Acid, Protein, and Methods for the Generation of Vaccine, Medicaments and Diagnostics
US20180059117A1 (en) * 2006-10-06 2018-03-01 Sirigen Inc. Fluorescent methods and materials for directed biomarker signal amplification
US20160231324A1 (en) * 2013-09-24 2016-08-11 The Regents Of The University Of California Encapsulated sensors and sensing systems for bioassays and diagnostics and methods for making and using them

Also Published As

Publication number Publication date
WO2021173865A2 (en) 2021-09-02

Similar Documents

Publication Publication Date Title
WO2021173865A3 (en) Compounds for detection of viral pathogens
CO2022010098A2 (en) Mutant kras protein inhibitors
MX2018009633A (en) Inhibitor of indoleamine-2,3-dioxygenase (ido).
GT201300093A (en) ANTIVIRAL COMPOUNDS
MX378854B (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS.
MX2015016776A (en) Fragrance composition.
EA202090693A1 (en) NEW MEK INHIBITOR FOR TREATMENT OF VIRAL AND BACTERIAL INFECTIONS
EA201692303A1 (en) NEW ANTI-INFECTION STRATEGY AGAINST COINFECTION CAUSED BY THE FLU VIRUS AND S.AUREUS
UA117518C2 (en) 6-CONDENSED HETEROARYLDHYDROPYRIMIDINS FOR THE TREATMENT AND PREVENTION OF HEPATITIS B INFECTION
MX2012008221A (en) Inhibitors of flaviviridae viruses.
MX2013004655A (en) Inhibitors of hepatitis c virus.
WO2007106404A3 (en) Vaccine for viruses that cause persistent or latent infections
MX2012008211A (en) Inhibitors of flaviviridae viruses.
MX2020011808A (en) Combinations and methods comprising a capsid assembly inhibitor.
MX2021010458A (en) Use of oncolytic viruses for the treatment of cancer.
PH12017502051A1 (en) TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF
PH12023500023A1 (en) Cdk2 degraders and uses thereof
EP4342545A3 (en) Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
MX379160B (en) Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
MX2022016281A (en) Broad spectrum antiviral compositions and methods.
MX2025003568A (en) Compounds and compositions useful as inhibitors of iaps
EA202190876A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EP4467198A3 (en) Fused tricyclic pyridazinone compounds and prodrugs thereof useful to treat orthomyxovirus infections
WO2022063869A3 (en) Compounds for the treatment of viral infections
AU2020903547A0 (en) Detection of pathogenic viruses

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21761619

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21761619

Country of ref document: EP

Kind code of ref document: A2